Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

Lidocaine   save search

Lidocaine Hydrochloride Market Forecasted to Reach USD 1.56 Billion by 2034 with Robust Growth in Asia Pacific Region
Published: 2024-03-21 (Crawled : 18:00) - prnewswire.com
AZNCF | News | $135.35 -3.53% -4.19% 0 twitter stocktwits trandingview |
Health Technology
| | O: 0.01% H: 0.0% C: 0.0%
JNJ | News | $148.53 -0.69% 0.18% 7.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.03% H: 0.0% C: 0.0%
AZN | News | $71.2 0.49% 0.46% 300K twitter stocktwits trandingview |
Health Technology
| | O: 1.34% H: 0.27% C: -0.63%

reach asia growth market
Ambarella Expands Autonomous Driving AI Domain Controller Family With Two New Members; Provides Broadest Software-Compatible AI Performance Range
Published: 2024-01-09 (Crawled : 10:00) - globenewswire.com
AMBA | $42.56 3.18% 3.06% 680K twitter stocktwits trandingview |
Electronic Technology
| | O: -1.13% H: 3.53% C: 1.97%

autonomous family
Kodiak Robotics Selects Ambarella AI Domain Controller SoC For Next-Generation Autonomous Trucks
Published: 2024-01-02 (Crawled : 10:00) - globenewswire.com
AMBA | $42.56 3.18% 3.06% 680K twitter stocktwits trandingview |
Electronic Technology
| | O: -1.52% H: 1.87% C: -0.36%

autonomous trucks
Ambarella Unveils Full Software Stack for Autonomous and Semi-Autonomous Driving, Optimized for its CV3-AD Central AI Domain Controller Family
Published: 2023-12-12 (Crawled : 10:00) - globenewswire.com
AMBA | $42.56 3.18% 3.06% 680K twitter stocktwits trandingview |
Electronic Technology
| | O: 0.1% H: 0.65% C: -1.03%

autonomous software family
Scilex Holding Company announces that ZTlido® (lidocaine topical system) will be added as a preferred agent to the Medicaid Preferred Drug List (PDL) in two new states: one Midwestern and one Southern State
Published: 2023-12-06 (Crawled : 14:30) - globenewswire.com
SCLX | $0.85 -12.97% -16.18% 1.7M twitter stocktwits trandingview |
| | O: 0.85% H: 1.68% C: -4.2%

ztlido drug company state one
Scilex Holding Company announces the addition of ZTlido® (lidocaine topical system) as a preferred agent to the Medicaid Preferred Drug List (PDL) of the State of Tennessee
Published: 2023-12-04 (Crawled : 14:00) - globenewswire.com
SCLX | $0.85 -12.97% -16.18% 1.7M twitter stocktwits trandingview |
| | O: 2.22% H: 5.43% C: -5.8%

ztlido drug company state
Scilex Holding Company Announces Issuance of a Second New Patent in the U.S. for Its Lead Commercial Product ZTlido® (lidocaine topical system)
Published: 2023-11-17 (Crawled : 17:00) - biospace.com/
SCLX | $0.85 -12.97% -16.18% 1.7M twitter stocktwits trandingview |
| | O: 5.61% H: 0.0% C: -5.31%

ztlido patent company commercial
Scilex Holding Company Announces Issuance of a Second New Patent in the U.S. for Its Lead Commercial Product ZTlido® (lidocaine topical system) for a Method of Relieving Pain Through the Application of a Non-Aqueous Lidocaine-Containing Patch
Published: 2023-11-17 (Crawled : 14:00) - globenewswire.com
SCLX | $0.85 -12.97% -16.18% 1.7M twitter stocktwits trandingview |
| | O: 5.61% H: 0.0% C: -5.31%

ztlido patent company commercial application
Scilex Holding Company Announces Issuance of New Patent in the U.S. for Its Lead Commercial Product ZTlido® (lidocaine topical system) for a Method of Relieving Pain Through the Application of a Lidocaine-Containing Patch
Published: 2023-11-15 (Crawled : 14:00) - globenewswire.com
SCLX | $0.85 -12.97% -16.18% 1.7M twitter stocktwits trandingview |
| | O: 3.25% H: 9.45% C: -0.79%

ztlido patent company commercial application
Scilex Holding Company Announces New Data From Deeper Skin Penetration Studies to Support SP-103 (lidocaine topical system) 5.4%, a Triple Strength Formulation of ZTlido®, in Treatment of Musculoskeletal Pain Disorders
Published: 2023-11-02 (Crawled : 13:00) - globenewswire.com
SCLX | $0.85 -12.97% -16.18% 1.7M twitter stocktwits trandingview |
| | O: 2.76% H: 7.53% C: -0.54%

sp-103 ztlido company disorders treatment skin
Scilex Holding Company Presented Oral and Poster Presentations on ZTlido (lidocaine topical system) at the 2023 Annual PAINWeek Conference Held in Las Vegas, NV
Published: 2023-09-12 (Crawled : 13:30) - globenewswire.com
SCLX | $0.85 -12.97% -16.18% 1.7M twitter stocktwits trandingview |
| | O: 2.49% H: 2.83% C: -1.21%
SRNE | $0.02 33.33% -8.85% 97K twitter stocktwits trandingview |
Health Technology
| | O: -3.62% H: 7.95% C: -8.1%

conference ztlido
Scilex Holding Company Announces Complete Enrollment of a Phase 2 Study to Evaluate the Safety and Efficacy of SP-103 (lidocaine topical system) 5.4%, Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain
Published: 2023-05-04 (Crawled : 13:00) - globenewswire.com
SCLX | $0.85 -12.97% -16.18% 1.7M twitter stocktwits trandingview |
| | O: 0.0% H: 4.91% C: -4.36%
SRNE | $0.02 33.33% -8.85% 97K twitter stocktwits trandingview |
Health Technology
| | O: -0.46% H: 2.92% C: -0.5%

sp-103 ztlido back treatment study
Lidocaine Ointment Market Report 2022: With Key Trends, Drivers, Players and Forecasts to 2030
Published: 2023-01-20 (Crawled : 23:00) - prnewswire.com
TARO | $42.2 -0.07% 0.0% 19K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

report market
Ambarella Expands CV3 Family of Automotive AI Domain Controllers With New CV3-AD685
Published: 2023-01-05 (Crawled : 17:00) - globenewswire.com
AMBA | $42.56 3.18% 3.06% 680K twitter stocktwits trandingview |
Electronic Technology
| | O: -0.95% H: 2.92% C: -0.84%

ad685 automotive
Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute LBP
Published: 2022-08-31 (Crawled : 08:00) - biospace.com/
SRNE | $0.02 33.33% -8.85% 97K twitter stocktwits trandingview |
Health Technology
| | O: 5.15% H: 2.94% C: 0.49%

sp-103 ztlido treatment fda designation granted fast track designation
Scilex Holding Company, a Sorrento Company, Announces That the FDA Has Granted Fast Track Designation for SP-103 (Lidocaine Topical System) 5.4%, Next Generation Triple Strength Formulation of ZTlido®, for the Treatment of Acute Low Back Pain (LBP)
Published: 2022-08-31 (Crawled : 04:00) - globenewswire.com
SRNE | $0.02 33.33% -8.85% 97K twitter stocktwits trandingview |
Health Technology
| | O: 5.15% H: 2.94% C: 0.49%

sp-103 ztlido treatment fda designation back granted fast track designation
Gainers vs Losers
61% 39%

Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M twitter stocktwits trandingview |

BHIL | $0.1793 -4.37% 19.24% 340K twitter stocktwits trandingview |
Agriculture, Forestry, Fishing ...

UMAC | $1.48 -1.33% 14.87% 20K twitter stocktwits trandingview |

CI | $352.28 -0.11% 13.53% 2 twitter stocktwits trandingview |
Health Services

CIG.C | $2.89 -1.37% 12.8% 2.3K twitter stocktwits trandingview |
n/a

MTH | $154.69 -2.21% 12.68% 450K twitter stocktwits trandingview |
Consumer Durables

HCP | News | $31.41 7.75% 11.26% 17M twitter stocktwits trandingview |

TSLA | News | $162.13 12.06% 10.13% 170M twitter stocktwits trandingview |
Consumer Durables

BMTX 4 | $1.545 0.98% 10.03% 2.5K twitter stocktwits trandingview |
Information

TAL | $12.26 0.57% 9.22% 12M twitter stocktwits trandingview |
Consumer Services


Your saved searches
Save your searches and get alerts when important news are released.